ResMed is a pioneer in sleep apnea treatment options. Established in 1989, ResMed has grown into a global leader in developing, manufacturing and distributing innovative medical devices such as CPAP machines and masks, as well as CPAP software solutions to better diagnose, treat, and manage sleep apnea, COPD and other respiratory diseases. In 2017, ResMed became an S&P 500 company with its annual revenues exceeding $2 billion. To date, ResMed operates in more than 120 countries and employs over 6,000 worldwide. Their mission is to change 20 million lives by 2020.